Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal
about
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implicationsHIV protease inhibitors: a review of molecular selectivity and toxicityHIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitusHIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.The New Epidemiology of HIV-Related Kidney Disease.Insulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study.GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.Pathogenesis and treatment of HIV lipohypertrophyProtease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion.HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer modelsBlunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAARTMolecular mechanisms for insulin resistance in treated HIV-infection.HIV medications: an update and review of metabolic complications.A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells.Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase.Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir.Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.
P2860
Q24598812-C28537F3-509B-4C4C-83CB-DB2C8B0962FAQ28082749-6C020DF3-C94D-4ACA-BBBD-E5A4DD0A636FQ28477208-FF534EEC-D114-4657-AC12-504BB8A16BD4Q28582686-33BBF62B-D188-48D8-80CF-7ECF3EC6ABCBQ33729269-E9390D00-EAAF-49A3-950A-F843A923C5A6Q33918414-C72E2029-7DAE-4AD9-9874-FC6073854E98Q34299021-C2A98B43-C79E-4140-BBA1-0A9888FF1042Q34307868-3F920CC7-7623-4B51-AD04-E74182AD5050Q34564051-2432F349-3146-442B-888C-60E75F656F35Q34737804-3258BAB9-D714-43B2-9E4E-A5595E0231F1Q35196656-F07BEC54-BF22-4913-A81A-637BAFDCD869Q36407276-753A8627-B71C-4F9B-A9CA-4D85E04ABE1CQ36900984-9B44F3AB-38A4-484F-B695-9BA246D99E67Q37162243-9BBA8C5C-3F7E-4469-B45E-4DEBF8891A3EQ37447923-CA80369A-A272-4760-9A16-9E4D41EFC880Q37604169-B57765DE-5056-42D4-A88A-EAB1A7133409Q37887885-36C94534-C038-4EDF-A0B1-6B0E32808568Q37981602-C4213265-244A-4F6E-86BE-437E68BA09EDQ39035319-68F7DB6C-9E01-4C97-8311-A47194F00BE6Q41920342-370272E5-355A-4E7D-B7F1-51BA0D70E313Q42176233-75A1347D-7E8B-4BF8-B1B9-DE6ADC5C874BQ55363508-EB012270-648A-4DCA-BA6E-34F0DF05B4AD
P2860
Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Direct comparison of the acute ...... on peripheral glucose disposal
@ast
Direct comparison of the acute ...... on peripheral glucose disposal
@en
Direct comparison of the acute ...... on peripheral glucose disposal
@nl
type
label
Direct comparison of the acute ...... on peripheral glucose disposal
@ast
Direct comparison of the acute ...... on peripheral glucose disposal
@en
Direct comparison of the acute ...... on peripheral glucose disposal
@nl
prefLabel
Direct comparison of the acute ...... on peripheral glucose disposal
@ast
Direct comparison of the acute ...... on peripheral glucose disposal
@en
Direct comparison of the acute ...... on peripheral glucose disposal
@nl
P2860
P1476
Direct comparison of the acute ...... on peripheral glucose disposal
@en
P2093
Qingyun Yan
P2860
P304
P356
10.1097/01.QAI.0000176654.97392.C7
P407
P50
P577
2005-12-01T00:00:00Z